David Rendall - Aug 1, 2023 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Role
Director
Signature
/s/ David Rendall
Stock symbol
PURE
Transactions as of
Aug 1, 2023
Transactions value $
$0
Form type
4
Date filed
8/3/2023, 04:23 PM
Previous filing
Oct 4, 2022
Next filing
Aug 22, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PURE Stock Option (Right to Buy) Award $0 +125K $0.00 125K Aug 1, 2023 Common Stock 125K $0.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2024 or January 15, 2024 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2025 or January 15, 2025.